C1 Inhibitor-C(1)over-bar-s complexes are internalized and degraded by the low density lipoprotein receptor-related protein

被引:38
作者
Storm, D
Herz, J
Trinder, P
Loos, M
机构
[1] Univ Mainz, Inst Med Microbiol & Hyg, D-55101 Mainz, Germany
[2] Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA
关键词
D O I
10.1074/jbc.272.49.31043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Like other serpin-enzyme complexes (SECs), proteinase-complexed C1 inhibitor (C1-INH) is rapidly cleared from the circulation and thought to be a neutrophil chemoattractant, suggesting that complex formation causes structural rearrangements exposing a domain which is recognized by specific cell surface receptors. However, the cellular receptor(s) responsible for the catabolism and potential mediation of chemotaxis by C1-INH-protease complexes remained obscure, To determine whether the SEC receptor mediates the binding and potential chemotaxis of C1-INH . C (1) over bar s, we performed binding assays with HepG2 cells, neutrophils, and monocytes, and the results show that C1-INH . C (1) over bar s neither bind to these cells nor cause a chemotactic response of neutrophils and monocytes, Furthermore, C1-INH . C (1) over bar s, the COOH-terminal C1 inhibitor peptide, or the tetrameric C1-INH . C (1) over bar s . C (1) over bar r . C1-INH complex were found to be significantly less effective in competing with the SEC receptor ligand I-125-peptide 105Y for the binding to HepG2; cells than unlabeled 105Y, indicating that the SEC receptor does not sufficiently recognize C1-INH-proteaae complexes. The asialoglycoprotein receptor was also ruled out to be responsible for the removal of the heavily glycosylated C1-INH . C (1) over bar s complex, since asialoorosomucoid did not compete for the clearance of C1-INH .I-125-C (1) over bar s and asialoglycoprotein receptor knockout mice showed no alterations in the C1-INH .I-125-C (1) over bar s clearance rate. We found that C1-INH .I-125-C (1) over bar s complexes were efficiently degraded by normal murine fibroblasts expressing the low density lipoprotein receptor-related protein (LRP) and cellular degradation was significantly reduced by chloroquine and the receptor-associated protein, which is a potent inhibitor of the binding of all known ligands to LRP. Moreover, receptor-associated protein inhibited the in vivo clearance of C1-INH .I-125-C (1) over bar s .,and murine fibroblasts genetically deficient for LRP did not degrade C1-INH .I-125-C (1) over bar s. Our results demonstrate that C1-INH . C (1) over bar s complexes do not stimulate neutrophil or monocytic chemotaxis but are removed by LRP, further underscoring its role as a serpin-enzyme complex clearance receptor.
引用
收藏
页码:31043 / 31050
页数:8
相关论文
共 55 条
  • [1] ACQUIRED C1 INHIBITOR (C1-INH) DEFICIENCY TYPE-II - REPLACEMENT THERAPY WITH C1-INH AND ANALYSIS OF PATIENTS C1-INH AND ANTI-C1-INH AUTOANTIBODIES
    ALSENZ, J
    LAMBRIS, JD
    BORK, K
    LOOS, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (06) : 1794 - 1799
  • [3] ARLAUD GJ, 1993, METHOD ENZYMOL, V223, P61
  • [4] CARBOHYDRATE-SPECIFIC RECEPTORS OF THE LIVER
    ASHWELL, G
    HARFORD, J
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 : 531 - 554
  • [5] DYSFUNCTIONAL C1BAR-INHIBITOR(AT), ISOLATED FROM A TYPE-II HEREDITARY-ANGIO-EDEMA PLASMA, CONTAINS A P1 REACTIVE CENTER (ARG-444-]HIS) MUTATION
    AULAK, KS
    PEMBERTON, PA
    ROSEN, FS
    CARRELL, RW
    LACHMANN, PJ
    HARRISON, RA
    [J]. BIOCHEMICAL JOURNAL, 1988, 253 (02) : 615 - 618
  • [6] BANDA MJ, 1988, J BIOL CHEM, V263, P4481
  • [7] HUMAN C1BAR INHIBITOR - PRIMARY STRUCTURE, CDNA CLONING, AND CHROMOSOMAL LOCALIZATION
    BOCK, SC
    SKRIVER, K
    NIELSEN, E
    THOGERSEN, HC
    WIMAN, B
    DONALDSON, VH
    EDDY, RL
    MARRINAN, J
    RADZIEJEWSKA, E
    HUBER, R
    SHOWS, TB
    MAGNUSSON, S
    [J]. BIOCHEMISTRY, 1986, 25 (15) : 4292 - 4301
  • [8] BRANDES ME, 1991, J IMMUNOL, V147, P1600
  • [9] CHEMOTAXIS OF POLYMORPHONUCLEAR NEUTROPHILS (PMN) IN PATIENTS SUFFERING FROM RECURRENT INFECTION
    BRENNEIS, H
    SCHMIDT, A
    BLAASMAUTNER, P
    WORNER, I
    LUDWIG, R
    HANSCH, GM
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (11) : 693 - 698
  • [10] COUTINHO M, 1994, J IMMUNOL, V153, P3648